Potential Therapeutic Targets for Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinoma

被引：0
|
作者：
Weiss, Vivian L.
Gonzalez, Raul S.
Shi, Chanjuan
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
818
引用
收藏
页码：206A / 207A
页数：2
相关论文
共 50 条
  • [31] Utility of CT in differentiating liver metastases of well-differentiated gastroenteropancreatic neuroendocrine neoplasms from poorly-differentiated neuroendocrine neoplasms
    Cui, Yong
    Li, Xiaoting
    Gao, Shunyu
    Li, Zhongwu
    Li, Yanling
    Lu, Ming
    Sun, Yingshi
    CHINESE JOURNAL OF CANCER RESEARCH, 2018, 30 (01) : 31 - 39
  • [32] MTOR EXPRESSION ANALYSIS IN LUNG AND GASTROENTEROPANCREATIC POORLY DIFFERENTIATED ENDOCRINE CARCINOMA (PDEC)
    Catena, L.
    Bajetta, E.
    Milione, M.
    Valente, M.
    Pusceddu, S.
    Ducceschi, M.
    Avarino, C.
    Pietrantonio, F.
    Biondani, P.
    Colonna, V.
    ANNALS OF ONCOLOGY, 2010, 21 : 265 - 265
  • [33] Survival After Resection of Poorly Differentiated Gastroenteropancreatic Neuroendocrine Neoplasm: Association of Nodal Involvement and Survival
    Thornblade, L.
    Melstrom, L.
    Warner, S.
    Ituarte, P.
    Chang, S.
    Li, D.
    Fong, Y.
    Singh, G.
    PANCREAS, 2021, 50 (03) : 460 - 460
  • [34] Response to temozolomide and bevacizumab in a patient with poorly differentiated neuroendocrine carcinoma
    Lindholm, Daniel P.
    Eriksson, Barbro
    Granberg, Dan
    MEDICAL ONCOLOGY, 2012, 29 (01) : 301 - 303
  • [35] Survival After Resection of Non-Disseminated yet Poorly Differentiated Gastroenteropancreatic Neuroendocrine Tumors
    Thornblade, L. W.
    Warner, S. G.
    Melstrom, L.
    Ituarte, P.
    Fong, Y.
    Singh, G.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S152 - S152
  • [36] Re: "Does surgery provide a survival advantage in nondisseminated poorly differentiated gastroenteropancreatic neuroendocrine neoplasms"
    Sabat, Claire
    Palmieri, Lola-jade
    Brezault, Catherine
    Ginestet, Claire
    Assaf, Antoine
    Coriat, Romain
    SURGERY, 2022, 171 (06) : 1443 - 1444
  • [37] Poorly differentiated neuroendocrine carcinoma of the breast with Merkel cell features
    Albright, Emily L.
    Keeney, Matthew E.
    Bashir, Amani
    Weigel, Ronald J.
    BREAST JOURNAL, 2018, 24 (04): : 644 - 647
  • [38] POORLY DIFFERENTIATED NEUROENDOCRINE CARCINOMA OF UNKNOWN PRIMARY TUMOR SITE
    GARROW, GC
    GRECO, FA
    HAINSWORTH, JD
    SEMINARS IN ONCOLOGY, 1993, 20 (03) : 287 - 291
  • [39] Mammalian Target of Rapamycin (mTOR) Expression Analysis and Therapeutic Approach in Lung and Gastroenteropancreatic Poorly Differentiated Endocrine Carcinoma (PDEC)
    Catena, L.
    Milione, M.
    Pusceddu, S.
    Ducceschi, M.
    Avarino, M.
    Valente, M.
    Colonna, V
    Barone, G.
    Bajetta, E.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 4 - 4
  • [40] Poorly Differentiated Neuroendocrine Small-Cell Carcinoma of the Gallbladder
    Benkel, M.
    Brasch, F.
    Neumann, J. D.
    Altendorf-Hofmann, A.
    Sendt, W.
    ZENTRALBLATT FUR CHIRURGIE, 2012, 137 (01): : 71 - 72
12345